Bio-Rad Laboratories | BIO - Operating Expenses


Bio-Rad Laboratories reported $7.17B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Abbott USD 10.46B 1.15B Jun/2026
Agilent USD 1.44B 9M Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Bruker USD 768.9M 44.3M Jun/2026
Charles River Laboratories USD 2.84B 1.96B Jun/2026
Danaher USD 52.58B 368M Jun/2026
General Electric Aerospace USD 17.64B 417M Jun/2026
Illumina USD 899M 47M Jun/2026
IQVIA Holdings USD 1.77B 4.45B Jun/2026
Laboratory Of America USD 3.27B 146.9M Jun/2026
Merck USD 15.77B 2.4B Jun/2026
Mettler Toledo International USD 739.77M 26.57M Jun/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quest Diagnostics USD 2.58B 88M Jun/2026
Repligen USD 183M 8.72M Jun/2026
Revvity USD 603.55M 24.8M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Siemens EUR 16.57B 2.29B Dec/2025
Standard Biotools USD 30.56M 15.16M Mar/2026
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Tosoh JPY 242.99B 4.79B Jun/2026
Waters USD 527M 592M Jun/2026